These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 28110193

  • 1. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
    Belemets N, Kobyliak N, Virchenko O, Falalyeyeva T, Olena T, Bodnar P, Savchuk O, Galenova T, Caprnda M, Rodrigo L, Skladany L, Delev D, Opatrilova R, Kruzliak P, Beregova T, Ostapchenko L.
    Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
    [Abstract] [Full Text] [Related]

  • 2. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats.
    Kobyliak N, Virchenko O, Falalyeyeva T, Kondro M, Beregova T, Bodnar P, Shcherbakov O, Bubnov R, Caprnda M, Delev D, Sabo J, Kruzliak P, Rodrigo L, Opatrilova R, Spivak M.
    Biomed Pharmacother; 2017 Jun; 90():608-614. PubMed ID: 28411553
    [Abstract] [Full Text] [Related]

  • 3. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
    Kobyliak N, Falalyeyeva T, Virchenko O, Mykhalchyshyn G, Bodnar P, Spivak M, Yankovsky D, Beregova T, Ostapchenko L.
    BMC Gastroenterol; 2016 Mar 15; 16():34. PubMed ID: 26976285
    [Abstract] [Full Text] [Related]

  • 4. Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles.
    Kobyliak N, Abenavoli L, Falalyeyeva T, Virchenko O, Natalia B, Beregova T, Bodnar P, Spivak M.
    Clujul Med; 2016 Mar 15; 89(2):229-35. PubMed ID: 27152074
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y, Shimada T, Iizuka S, Suzuki W, Makihara H, Teraoka R, Tsuneyama K, Hokao R, Aburada M.
    Eur J Pharmacol; 2011 Jul 15; 662(1-3):1-8. PubMed ID: 21549692
    [Abstract] [Full Text] [Related]

  • 7. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
    Coelho CFF, França LM, Nascimento JR, Dos Santos AM, Azevedo-Santos APS, Nascimento FRF, Paes AMA.
    J Dev Orig Health Dis; 2019 Apr 15; 10(2):188-195. PubMed ID: 29855396
    [Abstract] [Full Text] [Related]

  • 8. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K, Nishida T, Baba H, Taira S, Fujimoto M, Nomoto K, Hayashi S, Miwa S, Nakajima T, Sutoh M, Oda E, Hokao R, Imura J.
    J Gastroenterol Hepatol; 2014 Sep 15; 29(9):1736-43. PubMed ID: 24730643
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.
    Kobyliak N, Abenavoli L, Falalyeyeva T, Beregova T.
    Ann Hepatol; 2018 Sep 15; 17(1):153-161. PubMed ID: 29311399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J, van Pelt J, Korf H, Mathieu C, van der Schueren B, Lannoo M, Oyen T, Topal B, Fetter G, Nayler S, van der Merwe T, Windmolders P, Van Gaal L, Verrijken A, Hubens G, Gericke M, Cassiman D, Francque S, Nevens F, van der Merwe S.
    Gastroenterology; 2015 Sep 15; 149(3):635-48.e14. PubMed ID: 26028579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation.
    Wu S, Yano S, Hisanaga A, He X, He J, Sakao K, Hou DX.
    Mol Nutr Food Res; 2017 Apr 15; 61(4):. PubMed ID: 27935258
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis.
    Fujimoto M, Tsuneyama K, Nakanishi Y, Salunga TL, Nomoto K, Sasaki Y, Iizuka S, Nagata M, Suzuki W, Shimada T, Aburada M, Shimada Y, Gershwin ME, Selmi C.
    J Med Food; 2014 Mar 15; 17(3):374-83. PubMed ID: 24588719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.
    Hart KM, Fabre T, Sciurba JC, Gieseck RL, Borthwick LA, Vannella KM, Acciani TH, de Queiroz Prado R, Thompson RW, White S, Soucy G, Bilodeau M, Ramalingam TR, Arron JR, Shoukry NH, Wynn TA.
    Sci Transl Med; 2017 Jun 28; 9(396):. PubMed ID: 28659437
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.